NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-1,033 Cr | ₹-477 Cr | ₹-5.30 Cr | ₹-103 Cr | ₹-167 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-1,033 Cr |
Mar2023 | ₹-477 Cr |
Mar2022 | ₹-5.30 Cr |
Mar2021 | ₹-103 Cr |
Mar2020 | ₹-167 Cr |
How is Cash Flow from Investing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,033 Cr | Negative | |
Mar2023 | ₹-477 Cr | Negative | |
Mar2022 | ₹-5.30 Cr | Negative | |
Mar2021 | ₹-103 Cr | Negative | |
Mar2020 | ₹-167 Cr | - |
Compare Cash Flow from Investing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,070.4 Cr | -5.8% | 3.6% | -13.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.8% |
3.6% |
-13.6% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses